<table border="1"><tr><th>Surname</th><td><ul><li>Carbamazepin</li></ul></td></tr><tr><th>Other names</th><td><ul><li>5 | H | -Dibenz[ | b |, | f | ]acepine-5-carbamid | (IUPAC) | 5 | H | -Dibenzo[ | b |, | f | ]acepine-5-carboxamide | (medicine book) | Carbamazepinum | (Latin)</li></ul></td></tr><tr><th>Sum formula</th><td><ul><li>C | 15 | H | 12 | N | 2 | O</li></ul></td></tr><tr><th>Short description</th><td><ul><li>white to almost white, crystalline and polymorphic powder</li></ul></td></tr><tr><th>EC number</th><td><ul><li>206-062-7</li></ul></td></tr><tr><th>ECHA-InfoCard</th><td><ul><li>100.005.512</li></ul></td></tr><tr><th>PubChem</th><td><ul><li>2554</li></ul></td></tr><tr><th>DrugBank</th><td><ul><li>DB00564</li></ul></td></tr><tr><th>Wikidata</th><td><ul><li>Q410412</li></ul></td></tr><tr><th>ATC-Code</th><td><ul><li>N03 | AF01</li></ul></td></tr><tr><th>Substance class</th><td><ul><li>Antiepileptics</li></ul></td></tr><tr><th>Mechanism of action</th><td><ul><li>Blockade of sodium channels</li></ul></td></tr><tr><th>Molar mass</th><td><ul><li>236,27 g·mol | −1</li></ul></td></tr><tr><th>Aggregate state</th><td><ul><li>strong</li></ul></td></tr><tr><th>melting point</th><td><ul><li>191 °C (Polymorph I) | 174 °C (Polymorph III)</li></ul></td></tr><tr><th>Solubility</th><td><ul><li>very soluble in water (205 mg·l | −1 | ), slightly soluble in dichloromethane, slightly soluble in acetone and ethanol 96 %</li></ul></td></tr><tr><th></th><td><ul><li></li></ul></td></tr><tr><th>H- and P-seeds</th><td><ul><li>H | 302 | ‐ | 317 | ‐ | 319 | ‐ | 334 | ‐ | 412</li></ul></td></tr><tr><th>Toxicological data</th><td><ul><li>114 mg·kg | −1 | (LD | 50 |, mouse, i.p.)</li></ul></td></tr><tr><th>General</th><td><ul><li>French name | Carbamazepin | Other names | 5 | H | -Dibenz[ | b |, | f | ]azepin-5-carbamid | (IUPAC) | 5 | H | -Dibenzo[ | b |, | f | ]azepin-5-carboxamide | (medicine book) | Carbamazepinum | (Latin) | Sum formula | C | 15 | H | 12 | N | 2 | O | Short description | white to almost white, crystalline and polymorphic powder</li></ul></td></tr><tr><th>External Identifiers/Databases</th><td><ul><li>CAS Number | 298-46-4 | EC Number | 206-062-7 | ECHA InfoCard | 100.005.512 | PubChem | 2554 | DrugBank | DB00564 | Wikidata | Q410412 | CAS Number | 298-46-4 | EC Number | 206-062-7 | ECHA InfoCard | 100.005.512 | PubChem | 2554 | DrugBank | DB00564 | Wikidata | Q410412 | CAS Number | 298-46-4 | EC Number | 206-062-7 | ECHA InfoCard | 100.005.512 | PubChem | 2554 | DrugBank | DB00564 | Wikidata | Q410412</li></ul></td></tr><tr><th>Drug data</th><td><ul><li>ATC code | N03 | AF01 | active class | antiepileptics | active mechanism | blockade of sodium channels</li></ul></td></tr><tr><th>Characteristics</th><td><ul><li>Molar mass | 236.27 g·mol | −1 | Aggregate state | solid | melting point | 191 °C (Polymorph I) | 174 °C (Polymorph III) | solubility | very hard soluble in water (205 mg·l | −1 | ), slightly soluble in dichloromethane, slightly soluble in acetone and ethanol 96 %</li></ul></td></tr><tr><th>Safety Notes</th><td><ul><li>Please note the exemption from labelling for medicines, medical products, cosmetics, food and feed | H- and P-seats | H | 302 | ‐ | 317 | ‐ | 319 | ‐ | 334 | ‐ | 412 | P | 261 | ‐ | 280 | ‐ | 280 | ‐ | 342+311 | toxicological data | 114 mg·kg | −1 | (LD | 50 |, mouse, i.p.) | SI units are used as far as possible and as usual. If not otherwise noted, the data indicated apply under standard conditions.</li></ul></td></tr></table>